Dr. Tawagi is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1801 W Taylor St Ste 1e
Chicago, IL 60612Phone+1 312-355-1625Fax+1 312-355-1515
Education & Training
- University of OttawaMD, Fellowship in Genitourinary Oncology Clinical Research, 2021 - 2022
- Ochsner Clinic FoundationFellowship, Hematology and Medical Oncology, 2018 - 2021
- Trinity Health Ann Arbor HospitalResidency, Internal Medicine, 2015 - 2018
- St. George's University School of MedicineClass of 2015, Magna Cum Laude
Certifications & Licensure
- IL State Medical License 2022 - 2026
- LA State Medical License 2018 - 2022
- MI State Medical License 2015 - 2018
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- Member Iota Epsilon Alpha Academic Medical Honor Society
- Resident Research Award 2018
- Inpatient Senior Resident of the Year 2018
Publications & Presentations
PubMed
- 13 citationsStatin use improves the efficacy of nivolumab in patients with advanced renal cell carcinoma.Matteo Santoni, Francesco Massari, Marc R Matrana, Umberto Basso, Ugo De Giorgi
European Journal of Cancer. 2022-09-01 - 8 citationsRoutine Screening for Central and Primary Adrenal Insufficiency during Immune-Checkpoint Inhibitor Therapy: An Endocrinology Perspective for Oncologists.Irena Druce, Karine Tawagi, Julie L V Shaw, Andrea Ibrahim, Heather Lochnan
Current Oncology. 2022-07-02 - 67 citationsConcomitant Proton Pump Inhibitors and Outcome of Patients Treated with Nivolumab Alone or Plus Ipilimumab for Advanced Renal Cell Carcinoma.Veronica Mollica, Matteo Santoni, Marc R Matrana, Umberto Basso, Ugo De Giorgi
Targeted Oncology. 2022-01-01
Journal Articles
- Routine Screening for Central and Primary Adrenal Insufficiency during Immune-Checkpoint Inhibitor Therapy: An Endocrinology Perspective for OncologistsDruce, Irena, Karine Tawagi, Julie LV Shaw, Andrea Ibrahim, Heather Lochnan, and Michael Ong, Current Oncology, 2022
Other
- Female suicide rate jumps 50 percent since 2000Karine Tawagi, ABC News
https://abcnews.go.com/Health/female-suicide-rate-jumps-50-percent-2000/story?id=55906336 - Toddlers consuming too much added sugar, study findsKarine Tawagi, ABC News
https://abcnews.go.com/Health/toddlers-consuming-added-sugar-study-finds/story?id=55719076 - Food at work adds up to a lot of extra, often empty, calories: StudyKarine Tawagi, ABC News
https://abcnews.go.com/Health/food-work-adds-lot-extra-empty-calories-study/story?id=55763674 - Join now to see all
Press Mentions
- Here's Why COVID Cases Are Surging in Toronto Despite Early LockdownApril 11th, 2021
- UK COVID variant more transmissible but may not be more deadly, new studies indicateApril 14th, 2021
- Why America's Vaccine Database Could Lead to Confusion and Misuse: ANALYSISApril 25th, 2021
Professional Memberships
- Member
- Member
Other Languages
- French
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: